Annual report pursuant to Section 13 and 15(d)

Restricted Cash Equivalents and Investments (Schedule of Cash Equivalents and Available-for-Sale Securities) (Details)

v3.23.1
Restricted Cash Equivalents and Investments (Schedule of Cash Equivalents and Available-for-Sale Securities) (Details)
Dec. 31, 2022
USD ($)
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost $ 3,694,069
Gross Unrealized Gains
Gross Unrealized Losses (48,841)
Fair Value 3,645,228
Cash Equivalents 978,462
Short-Term Investments 2,666,766
Long-Term Investments
Restricted Cash Equivalents [Member]  
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost 978,462
Gross Unrealized Gains
Gross Unrealized Losses
Fair Value 978,462
Cash Equivalents 978,462
Short-Term Investments
Long-Term Investments
Money Market Funds [Member]  
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost 978,462
Gross Unrealized Gains
Gross Unrealized Losses
Fair Value 978,462
Cash Equivalents 978,462
Short-Term Investments
Long-Term Investments
Investments [Member]  
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost 2,715,607
Gross Unrealized Gains
Gross Unrealized Losses (48,841)
Fair Value 2,666,766
Cash Equivalents
Short-Term Investments 2,666,766
Long-Term Investments
Corporate Notes/Bonds [Member]  
Schedule of Available-for-sale Securities [Line Items]  
Amortized Cost 2,715,607
Gross Unrealized Gains
Gross Unrealized Losses (48,841)
Fair Value 2,666,766
Cash Equivalents
Short-Term Investments 2,666,766
Long-Term Investments